Literature DB >> 7812991

Determination of appropriate clomipramine dosage among depressed African outpatients in Dar es Salaam, Tanzania.

G P Kilonzo1, S F Kaaya, J K Rweikiza, M Kassam, G Moshi.   

Abstract

In an open clomipramine dose finding study, 33 depressed indigenous African outpatients were randomly assigned to two regimens of treatment with 125 mg and 75 mg oral medications daily. At the end of eight weeks of treatment, 16 patients (48.5 pc) were on the 75 mg regime, and 17 (54.8 pc) were on 125 mg. Analysis of depression scores on the Beck-Rafaelsen scale indicated improvements of depression in both regimes of equal magnitude. Analysis of variance showed no statistically significant difference on dose response between the two regimes. The higher doses, however, were associated with more drowsiness and tremulousness. It is suggested that Black African patients respond to tricyclic antidepressants in much lower doses than those recommended in Western textbooks. It is also apparent that side effects of tricyclic antidepressants, which have been implicated in non-compliance to medication, could be avoided without compromising treatment outcome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812991

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  5 in total

Review 1.  Pharmacological treatment of severe psychiatric disorders in the developing world : lessons from India.

Authors:  Vikram Patel; Chittaranjan Andrade
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Feasibility of nurse-led antidepressant medication management of depression in an HIV clinic in Tanzania.

Authors:  Julie L Adams; Maria L G Almond; Edward J Ringo; Wahida H Shangali; Kathleen J Sikkema
Journal:  Int J Psychiatry Med       Date:  2012       Impact factor: 1.210

3.  Which antidepressants are best tolerated in primary care? A pilot randomized trial from goa.

Authors:  J Pereira; V Patel
Journal:  Indian J Psychiatry       Date:  1999-10       Impact factor: 1.759

4.  Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.

Authors:  Ma-Li Wong; Chuanhui Dong; Deborah L Flores; Monika Ehrhart-Bornstein; Stefan Bornstein; Mauricio Arcos-Burgos; Julio Licinio
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 5.  Packages of care for depression in low- and middle-income countries.

Authors:  Vikram Patel; Gregory Simon; Neerja Chowdhary; Sylvia Kaaya; Ricardo Araya
Journal:  PLoS Med       Date:  2009-10-06       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.